INSIGHTS ON DRUG DEVELOPMENT

• Shining A Light On Dark Data

  Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.

• Strategic Early Material Generation For Accelerated Process Development

  Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

• Deciphering Nanoparticle Properties With AF4

  Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.

• From Lipids To Launch: End-To-End Therapy Development

  Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.

• The Top Tech Transfer Risks At Multi-Site CDMOs

  3/31/2026

  Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.

• Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies

  7/15/2026

  Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

• ADC Tech Talks Contract Manufacturing

  12/9/2024

  Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.

• Biophysical Tools For Biotherapeutic Development

  6/26/2025

  Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.

• How Can Biopharma Overcome Digital Transformation Failure?

  8/17/2026

  Biopharma understands the promise of digital transformation, but implementation remains the challenge. Learn why organizational structures must evolve to turn strategies into scalable results.